Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

USA - NYSE:BXC - US09624H2085 - Common Stock

78.36 USD
+1.95 (+2.55%)
Last: 9/18/2025, 4:15:01 PM
78.36 USD
0 (0%)
After Hours: 9/18/2025, 4:15:01 PM
Fundamental Rating

4

Overall BXC gets a fundamental rating of 4 out of 10. We evaluated BXC against 50 industry peers in the Trading Companies & Distributors industry. Both the profitability and the financial health of BXC get a neutral evaluation. Nothing too spectacular is happening here. BXC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BXC had positive earnings in the past year.
BXC had a positive operating cash flow in the past year.
BXC had positive earnings in each of the past 5 years.
Each year in the past 5 years BXC had a positive operating cash flow.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.79%, BXC is doing worse than 62.00% of the companies in the same industry.
The Return On Equity of BXC (4.57%) is comparable to the rest of the industry.
BXC has a worse Return On Invested Capital (3.08%) than 70.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BXC is in line with the industry average of 10.24%.
The 3 year average ROIC (11.49%) for BXC is well above the current ROIC(3.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROIC 3.08%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

With a Profit Margin value of 0.96%, BXC is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of BXC has declined.
BXC's Operating Margin of 2.09% is on the low side compared to the rest of the industry. BXC is outperformed by 72.00% of its industry peers.
BXC's Operating Margin has improved in the last couple of years.
BXC has a worse Gross Margin (15.94%) than 88.00% of its industry peers.
BXC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BXC is creating some value.
BXC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BXC has been reduced compared to 5 years ago.
The debt/assets ratio for BXC has been reduced compared to a year ago.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BXC has an Altman-Z score of 3.49. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.49, BXC is in the better half of the industry, outperforming 62.00% of the companies in the same industry.
A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.96, BXC is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.49
ROIC/WACC0.33
WACC9.25%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BXC has a Current Ratio of 4.55. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BXC (4.55) is better than 94.00% of its industry peers.
BXC has a Quick Ratio of 2.94. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
BXC has a Quick ratio of 2.94. This is amongst the best in the industry. BXC outperforms 96.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 2.94
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -63.76% in the last year.
The earnings per share for BXC have been decreasing by -40.26% on average. This is quite bad
BXC shows a decrease in Revenue. In the last year, the revenue decreased by -2.32%.
The Revenue has been growing slightly by 2.28% on average over the past years.
EPS 1Y (TTM)-63.76%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-58.33%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%1.53%

3.2 Future

Based on estimates for the next years, BXC will show a very negative growth in Earnings Per Share. The EPS will decrease by -24.98% on average per year.
Based on estimates for the next years, BXC will show a small growth in Revenue. The Revenue will grow by 2.90% on average per year.
EPS Next Y-76.57%
EPS Next 2Y-24.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.35%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.20, which indicates a rather expensive current valuation of BXC.
Compared to the rest of the industry, the Price/Earnings ratio of BXC indicates a somewhat cheap valuation: BXC is cheaper than 62.00% of the companies listed in the same industry.
BXC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 21.82 indicates a rather expensive valuation of BXC.
BXC's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.70. BXC is around the same levels.
Industry RankSector Rank
PE 22.2
Fwd PE 21.82
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BXC is valued a bit cheaper than 78.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.35
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as BXC's earnings are expected to decrease with -24.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BXC!.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (9/18/2025, 4:15:01 PM)

After market: 78.36 0 (0%)

78.36

+1.95 (+2.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners95.61%
Inst Owner Change-4.96%
Ins Owners2.21%
Ins Owner Change0.56%
Market Cap618.26M
Analysts77.5
Price Target83.64 (6.74%)
Short Float %6.05%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.89%
Min EPS beat(2)-24.67%
Max EPS beat(2)0.88%
EPS beat(4)3
Avg EPS beat(4)13.48%
Min EPS beat(4)-24.67%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)23.04%
EPS beat(12)8
Avg EPS beat(12)14.37%
EPS beat(16)12
Avg EPS beat(16)22.17%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-1.23%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-2.07%
Revenue beat(12)2
Avg Revenue beat(12)-3.74%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)0%
PT rev (3m)-10.14%
EPS NQ rev (1m)-25.58%
EPS NQ rev (3m)-48.49%
EPS NY rev (1m)-51.91%
EPS NY rev (3m)-51.91%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.9%
Revenue NY rev (1m)-0.73%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE 22.2
Fwd PE 21.82
P/S 0.21
P/FCF N/A
P/OCF 31.16
P/B 1
P/tB 1.14
EV/EBITDA 8.35
EPS(TTM)3.53
EY4.5%
EPS(NY)3.59
Fwd EY4.58%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)2.51
OCFY3.21%
SpS373.54
BVpS78.75
TBVpS68.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROCE 4.59%
ROIC 3.08%
ROICexc 4.33%
ROICexgc 4.73%
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
FCFM N/A
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexcg growth 3Y-37.08%
ROICexcg growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score3
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 6
Cap/Depr 115.37%
Cap/Sales 1.48%
Interest Coverage 1.33
Cash Conversion 19.97%
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 2.94
Altman-Z 3.49
F-Score3
WACC9.25%
ROIC/WACC0.33
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-63.76%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-58.33%
EPS Next Y-76.57%
EPS Next 2Y-24.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%1.53%
Revenue Next Year1.35%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.23%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year-5.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.85%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-95.59%
OCF growth 3Y-16.25%
OCF growth 5YN/A